Flerie Invest
Stockholmflerie.com
Overview
Flerie Invest is a publicly traded, long-term global venture capital firm that invests in early-stage and growth-stage companies in the life science, biotech, and pharma sectors. Based in Stockholm, Sweden, and London, United Kingdom, the firm manages a portfolio of companies across Europe, Israel, and the US. Flerie operates through three segments: Product Development, Commercial Growth, and Limited Partnerships, where it also invests in other funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Numab Therapeutics | Jan 2025 | Series C Extension | - |
| Symcel | Mar 2024 | VC Round | Co-investor |
| Prokarium | Feb 2023 | Series C | Co-investor |
| Inversago Pharma | Oct 2022 | Series C | - |
| Geneos Therapeutics | Mar 2022 | Series A Extension | Lead |
Key People
Michaela Gertz
Chief Financial Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
